跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ambrazole - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ambrazole
Approved
STANDARD
Ambrazole
CSPC Ouyi Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
08bc87ac3f1a8a80
Company
CSPC Ouyi Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
08bc87ac3f1a8a80
Drug Approval Philippines Name
Ambrazole
Product Name
Ambrazole
Registration Number
DRP-3590
Brand Name
Ambrazole
Generic Name
Omeprazole (As Sodium)
Dosage Form
Powder For Injection (Iv)
Dosage Strength
40 mg
Manufacturer
CSPC Ouyi Pharmaceutical Co., Ltd.
Importer
AMB HK Enterprises, Inc.
Distributor
AMB HK Enterprises, Inc.
Company Detail Path
/organization/cspc-ouyi-pharmaceutical-co-ltd
Issuance Date
14 July 2023
Expiry Date
14 July 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
08bc87ac3f1a8a80
Type
Standard
Back to Philippines FDA Approvals